Clinical efficacy and safety maintained up to 5 years in patients with rheumatoid arthritis treated with tocilizumab in a randomised trial. - Concepedia

Concepedia

Publication | Closed Access

Clinical efficacy and safety maintained up to 5 years in patients with rheumatoid arthritis treated with tocilizumab in a randomised trial.

25

Citations

0

References

2016

Year

Joel M. Kremer, Ricardo Blanco, Anne-Marie Halland, Marek Brzosko, Rubén Burgos‐Vargas, Christopher M. Mela, Lucy Rowell, Roy Fleischmann

Abstract

Over 5 years, tocilizumab + MTX inhibited radiographic progression and maintained improvements in signs and symptoms and physical function in MTX-inadequate responders with active disease; no new safety signals occurred.